p16 immunohistochemical marker was recently tested in a few types of cancers in Egyptian patients revealing a potential role in carcinogenesis such as colorectal cancers [60], basal cell carcinoma [61], ovarian germ cell tumors [62], and cervical carcinoma [63]. This evidence concerns the gene CDKN2A and basal cell carcinoma.